title: Ceramide synthase-dependent ceramide generation and programmed cell death: involvement of salvage pathway in regulating postmitochondrial events.
abstract: The sphingolipid ceramide has been widely implicated in the regulation of programmed cell death or apoptosis. The accumulation of ceramide has been demonstrated in a wide variety of experimental models of apoptosis and in response to a myriad of stimuli and cellular stresses. However, the detailed mechanisms of its generation and regulatory role during apoptosis are poorly understood. We sought to determine the regulation and roles of ceramide production in a model of ultraviolet light-C (UV-C)-induced programmed cell death. We found that UV-C irradiation induces the accumulation of multiple sphingolipid species including ceramide, dihydroceramide, sphingomyelin, and hexosylceramide. Late ceramide generation was also found to be regulated by Bcl-xL, Bak, and caspases. Surprisingly, inhibition of de novo synthesis using myriocin or fumonisin B1 resulted in decreased overall cellular ceramide levels basally and in response to UV-C, but only fumonisin B1 inhibited cell death, suggesting the presence of a ceramide synthase (CerS)-dependent, sphingosine-derived pool of ceramide in regulating programmed cell death. We found that this pool did not regulate the mitochondrial pathway, but it did partially regulate activation of caspase-7 and, more importantly, was necessary for late plasma membrane permeabilization. Attempting to identify the CerS responsible for this effect, we found that combined knockdown of CerS5 and CerS6 was able to decrease long-chain ceramide accumulation and plasma membrane permeabilization. These data identify a novel role for CerS and the sphingosine salvage pathway in regulating membrane permeability in the execution phase of programmed cell death.
authors.affiliation: Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Mullen
authors.forename: Russell W
authors.initials: RW
authors.lastname: Jenkins
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Clarke
authors.forename: Jacek
authors.initials: J
authors.lastname: Bielawski
authors.forename: Yusuf A
authors.initials: YA
authors.lastname: Hannun
authors.forename: Lina M
authors.initials: LM
authors.lastname: Obeid
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D053179:Caspase 7 / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D002518:Ceramides / Q000235:genetics / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D037341:Fumonisins / Q000494:pharmacology; D006801:Humans; D010088:Oxidoreductases / Q000235:genetics / Q000378:metabolism*; D013110:Sphingosine / Q000235:genetics / Q000378:metabolism*; D014466:Ultraviolet Rays / Q000009:adverse effects; D050998:bcl-2 Homologous Antagonist-Killer Protein / Q000235:genetics / Q000378:metabolism; D051020:bcl-X Protein / Q000235:genetics / Q000378:metabolism
chemical_list: C494772:BAK1 protein, human; C494811:BCL2L1 protein, human; D002518:Ceramides; D004791:Enzyme Inhibitors; D037341:Fumonisins; D050998:bcl-2 Homologous Antagonist-Killer Protein; D051020:bcl-X Protein; C056933:fumonisin B1; D010088:Oxidoreductases; C108138:dihydroceramide desaturase; C505520:CASP7 protein, human; D053179:Caspase 7; D013110:Sphingosine